{"id":"W2149270596","doi":"10.2147/pgpm.s55339","title":"Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancer","year":2014,"lang":"en","type":"review","venue":"Pharmacogenomics and Personalized Medicine","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"Academy of Medical Sciences; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Afatinib; Medicine; Epidermal growth factor receptor; T790M; Lung cancer; Adenocarcinoma; EGFR inhibitors; Precision medicine; Drug resistance; Oncology; Targeted therapy; Osimertinib; Cancer research; Gefitinib; Cancer; Erlotinib; Internal medicine; Pathology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007110504,0.0006288835,0.001065238,0.002206769,0.0002771158,0.0009148607,0.0006364869,0.001193972,0.002673044],"category_scores_gemma":[0.0005425463,0.0002928235,0.0006998826,0.002124544,0.0004839399,0.001520314,0.0006760126,0.002508957,0.001895241],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007553516,"about_ca_system_score_gemma":0.0009738253,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009232567,"about_ca_topic_score_gemma":0.00207289,"domain_scores_codex":[0.999763,0.00004881841,0.00002780554,0.00003451087,0.0001073874,0.00001855714],"domain_scores_gemma":[0.9997656,0.000112675,0.00002873742,0.00001023442,0.000066767,0.00001605709],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004773703,0.00009277288,0.0001356009,0.01328638,0.0001190285,0.0002783488,0.00008515055,0.0006220062,0.003539427,0.009926025,0.02555908,0.9463083],"study_design_scores_gemma":[0.00001642792,0.00007844545,0.0004579336,0.002045316,0.00007073701,0.001302797,0.00004149845,0.0001641598,0.0006803928,0.003685637,0.9914393,0.00001730137],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001304785,0.9974667,0.0003789953,0.0004339386,0.0001752444,0.000007130961,0.00001414514,0.00001133468,0.001381973],"genre_scores_gemma":[0.0007552629,0.9976249,0.0005152131,0.0003013583,0.0001280438,0.000007273398,0.00002092065,0.000001638394,0.0006454108],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002673044,"threshold_uncertainty_score":0.008942187,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09332858321314516,"score_gpt":0.4054736549770533,"score_spread":0.3121450717639082,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}